000			01766 a2200409 4500
005			20250517200710.0
264		0	_c20190719
008			201907s 0 0 eng d
022			_a1528-3933
024	7		_a10.1016/j.jaapos.2017.10.016 _2doi
040			_aNLM _beng _cNLM
100	1		_aBata, Bashar M
245	0	0	_aCombined intraocular and systemic rituximab for ocular lymphoproliferative disorder with extranodal marginal zone lymphoma-type morphology after heart transplant. _h[electronic resource]
260			_bJournal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus _c04 2018
300			_a159-161 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents, Immunological _xtherapeutic use
650	0	4	_aChild
650	0	4	_aHeart Transplantation
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aInjections, Intraocular
650	0	4	_aIris Neoplasms _xdrug therapy
650	0	4	_aLymphoma, B-Cell, Marginal Zone _xdrug therapy
650	0	4	_aLymphoproliferative Disorders _xdrug therapy
650	0	4	_aMale
650	0	4	_aPostoperative Complications _xdrug therapy
650	0	4	_aRituximab _xtherapeutic use
700	1		_aPulido, Jose S
700	1		_aPatel, Sanjay V
700	1		_aKhan, Shakila P
700	1		_aSalomao, Diva
700	1		_aBoyce, Thomas G
700	1		_aBothun, Erick D
773	0		_tJournal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus _gvol. 22 _gno. 2 _gp. 159-161
856	4	0	_uhttps://doi.org/10.1016/j.jaapos.2017.10.016 _zAvailable from publisher's website
999			_c28051616 _d28051616